Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61827 |
RJ-34
|
||
RJ-34, an aristolactam analogue, demonstrates strong antitumor effects across a wide range of cancer cell lines, with subnanomolar GI 50 values (GI 50 <0.1 nM) observed for A431, MES-SA, MES-SA/DX5, HCT-15, and HCT-15/CLO2 cells [1]. |